The high concentration of AP, keytika, at, CD20 and alpha include the alpha, tau, sigma, Omega, alpha, kappa, and alpha

摘要

The present invention relates to an antibody to the active [phi] alpha [phi] P [alpha] a [phi] a [phi] a [alpha] kappa] e [CD20] in a high concentration pharmaceutical preparation, for example. Rituximab, _kappa p p p p a lambda__mu_ pi_, or a mixture of Hu muab CD20 antibodies, or subcutaneous injection.In particular, the preparations of the invention include at least one effective dose of CD20 antibody. A preparation used as a combination of_alpha lambda_rho__delta__in an enzyme preparation to form one or more active substances. In addition, the preparation includes at least one regulatory factor, for example.A mixture of buffering factor X histidine, stabilizer, or stabilizer (e.g. two or more_alpha kappa_alpha rho_stabilizers). Trehalose dihydrate (a-a or sucrose and optional second methionine) as a nonionic surfactant, stabilizer, and an effective slope At least one enzyme is supplied.The preparation method and application of the preparation are provided.